This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
NattoPharma : Files for Delisting from Euronext Expand MT
NattoPharma : Lesaffre to Acquire Remaining Shares in NattoPharma MT
NattoPharma : France's Lesaffre To Launch Compulsory Offer To Buy Remaining NattoPharma Shares MT
NattoPharma : France's Lesaffre Completes Acquisition of NattoPharma MT
NattoPharma : Lesaffre to Proceed with Squeeze Out of NattoPharma Shares Following Mandatory Offer MT
NattoPharma : Lesaffre Secures 98% Stake In NattoPharma as Mandatory Offer Period Ends MT
Compagnie Des Levures Lesaffre completed the acquisition of remaining 23% stake in NattoPharma ASA (OB:NATTO) CI
NattoPharma : Lesaffre Launches Mandatory Offer For NattoPharma MT
Compagnie Des Levures Lesaffre SA launched a mandatory offer to acquire remaining 23% stake in NattoPharma ASA (OB:NATTO) for approximately NOK 170 million. CI
NattoPharma : Lesaffre Completes Settlement of All NattoPharma Options Pursuant to Takeover MT
NattoPharma : Lesaffre Closes Voluntary Offer to Buy NattoPharma Shares MT
NattoPharma ASA Terminates Contract with Norne Securities AS CI
NattoPharma : Wins 76% Valid Acceptances For $85 Million Compagnie des Levures Lesaffre Offer MT
NattoPharma : Lesaffre's NattoPharma Takeover Voluntary Offer Period Ends MT
Compagnie Des Levures Lesaffre SA completed the acquisition of 76.43% stake in NattoPharma ASA (OB:NATTO) from Synergia Sciences Pvt. Ltd. and others for approximately NOK 560 million. CI
NattoPharma ASA (OB:NATTO) completed the acquisition of an additional 41.31% minority stake in Kaydence Pharma AS for NOK 11.4 million. CI
NattoPharma : Lesaffre Takeover of NattoPharma Gets Norwegian Competition Authority Clearance MT
NattoPharma : French Suitor Lesaffre Submits Voluntary Cash Offer MT
NattoPharma : Lesaffre's Takeover Bid for NattoPharma Achieves Minimum Acceptance Level MT
Transcript : NattoPharma ASA, Q4 2020 Earnings Call, Feb 17, 2021
Nattopharma Asa Reports Earnings Results for the Fourth Quarter Ended December 31, 2020 CI
NattoPharma : Lesaffre Offers to Buy NattoPharma in $75 Million Deal MT
NattoPharma ASA (OB:NATTO) made an offer to acquire the remaining 45.9% stake in Kaydence Pharma AS for NOK 12.7 million. CI
Compagnie Des Levures Lesaffre SA made a tender offer to acquire NattoPharma ASA (OB:NATTO) from Synergia Sciences Pvt. Ltd. and others for approximately NOK 740 million. CI
Nattopharma & Cardiovascular Research Institute Maastricht Renew Long-Standing Vitamin K2 Research Partnership CI
Chart NattoPharma ASA
More charts
Nattopharma ASA is a Norway-based biotechnology company, which sells and develops products containing natural vitamin K2. The Company markets its products under its own trademark MenaQ7, principally in Europe and North America. MenaQ7 is provided either as powder or as an oil solution, and is used in stand-alone form, in complex dietary products and as additives to functional products. Nattopharma ASA offers contract manufacturing of dietary products, biochemical tests, marketing and sales support services. It provides its products primarily to the healthcare, supplement and functional food markets. The Company has an alliance with VitaK BV, at the Cardiovascular Research Institute (CARIM) at the University of Maastricht in the Netherlands.
More about the company
  1. Stock Market
  2. Equities
  3. NATTO Stock
  4. News NattoPharma ASA
  5. NattoPharma : Wins 76% Valid Acceptances For $85 Million Compagnie des Levures Lesaffre Offer